publication date: Dec. 16, 2016

Obama Signs Cures Act, Funding Biden’s Moonshot and Boosting NIH, NCI, FDA Budgets Over 10 Years

By Matthew Bin Han Ong

President Barack Obama Dec. 13 signed the 21st Century Cures Act, a bill that changes regulatory standards at FDA, slates additional research funds for NIH, and authorizes $1.8 billion over seven years for Vice President Joe Biden’s National Cancer Moonshot Initiative.

The legislation, a $6.3 billion health care reform measure designed to accelerate drug development and modernize clinical trials, was signed into law during an unusual legislative period.

The federal government is running on its second FY 2017 continuing resolution, which was approved by a lame-duck, GOP-led Congress determined to align funding priorities with President-Elect Donald Trump’s administration (The Cancer Letter, Nov. 18).

“I started the 2016 State of the Union address by saying we might be able to surprise some cynics and deliver bipartisan action on the opioid epidemic,” Obama said at the signing ceremony Dec. 13. “And in that same speech, I put Joe in charge of mission control on a new Cancer Moonshot.

“And today, with the 21st Century Cures Act, we are making good on both of those efforts. We are bringing to reality the possibility of new breakthroughs to some of the greatest health challenges of our time.”

Biden praised lawmakers for their bipartisan work on the bill. The moonshot initiative, renamed “Beau Biden Cancer Moonshot,” will be implemented through targeted, multi-year funding authorized through the Cures Act (The Cancer Letter, Dec. 9).

“When the president asked me last year at the State of the Union to head the Cancer Moonshot, we said we were going to ask you all for significant funding increases … Continue reading Obama Signs Cures Act, Funding Biden’s Moonshot and Boosting NIH, NCI, FDA Budgets Over 10 Years

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.